Abdulrehman, J., Zarabi, S., Elbaz, C., deWit, K., Lin, Y., Sholzberg, M., & Selby, R. (2021, July). Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals. Research and Practice in Thrombosis and Haemostasis.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Abdulrehman, Jameel, Sahar Zarabi, Carolyne Elbaz, Kerstin deWit, Yulia Lin, Michelle Sholzberg, و Rita Selby. "Safety of Idarucizumab in the Reversal of Dabigatran at Six Tertiary Care Ontario Hospitals." Research and Practice in Thrombosis and Haemostasis Jul. 2021.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Abdulrehman, Jameel, et al. "Safety of Idarucizumab in the Reversal of Dabigatran at Six Tertiary Care Ontario Hospitals." Research and Practice in Thrombosis and Haemostasis, Jul. 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.
